Research Report: Home
Welcome Messages
2007 Statistics
Year in Review
OCI : TGRI : TWRI
Honour Roll
CFI Grants Boost Funding
McEwen Centre Launches
Funding
Committees

Research Funding Revenues

UHN Core Research Funding
(in thousands of dollars)
 
Princess Margaret Hospital Foundation
15,341
Toronto General & Western Hospital Foundation
2,502

Arthritis & Autoimmunity Research Centre Foundation

1,259
Ministry of Health & Long Term Care
2,850
Recoveries
7,652
Investment income

2,814

Other

13,213

TOTAL
45,631
UHN External Research Funding
(in thousands of dollars)
 
Operating Grants
74,719
Infrastructure / Maintenance Awards
24,339

Clinical Studies

17,997
Other
9,759
Career / Traineeship Awards
7,642
Corporate Contracts

7,225

TOTAL
141,681
 
Major Sources of External Funding
(in thousands of dollars)
 
Canadian Institutes of Health Research
24,653
Canada Foundation for Innovation/OIT
22,318

National Cancer Institute of Canada

7,275
National Institutes of Health (US)
6,843
Ontario Institute for Cancer Research
4,581
Heart and Stroke Foundations

3,973

Ontario Genomics Institute
2,726
Canada Research Chairs Program

2,556


All figures represent fiscal year 2006/07 and include Ontario Cancer Institute (Princess Margaret Hospital); Toronto General Research Institute (Toronto General Hospital); and Toronto Western Research Institute (Toronto Western Hospital).


These figures have been provided by UHN Research Financial Services and Research Grant and Contract Services. These figures have not been audited. However, they have been included in the overall UHN statements and, as a result, have been subjected to audit procedures deemed appropriate by auditors in order to determine their overall reasonableness.

 

 
External Agencies Funding UHN Research
A-C
Full Listing
Abbott Laboratories
Advanced Cardiovascular Systems
Advanced Neuromodulation Systems
Aegera Therapeutics
Agouron Pharma
Albert Einstein College of Medicine of Yeshiva University
Alberta Heritage Foundation for Medical Research
Alexion Pharmaceuticals
Allergan
American Association for Thoracic Surgery
American Association of Neurological Surgeons
American Cytoscope Makers
American Heart Association
American Society of Plastic Surgeons' Plastic Surgery Educational Foundation
American Society of Regional Anesthesia and Pain Medicine
Amgen
Amorfix Life Sciences
Amyotrophic Lateral Sclerosis Society of Canada
AOSpine North America
ArgiNOx Pharmaceuticals
Argonne National Laboratory
Argos Therapeutics
Arius Research
Arthritis Community Research & Evaluation Unit
Arthritis Society
Aspreva
Astellas Pharma Canada
Astra Pharma
AstraZeneca Canada
AtheroGenics
Atuka
Aventis Pasteur
Banting and Best Diabetes Centre
Bausch and Lomb
Baxter Healthcare
Baycrest
Bayer
Beckman Coulter
Bell Canada
BioAxone Therapeutic
BioChem Therapeutic
BioMimetic Therapeutics
Boehringer Ingelheim
Boston Scientific
Bristol-Myers Squibb
Burroughs Wellcome Fund
CAD Sciences
Calouste Gulbenkian Foundation
Canada Foundation for Innovation
Canada Research Chairs Program
Canadian Arthritis Network
Canadian Association of Gastroenterology
Canadian Breast Cancer Foundation
Canadian Breast Cancer Research Alliance
Canadian Breast Cancer Research Initiative
Canadian Coordinating Office for Health Technology Assessment
Canadian Cystic Fibrosis Foundation
Canadian Diabetes Association
Canadian Health Services Research Foundation
Canadian Institutes of Health Research
Canadian Liver Foundation
Canadian Neuromodulation Society
Canadian Patient Safety Institute
Canadian Urologic Oncology Group
Cancer Care Ontario
Cancer Research Institute
Cancer Research Society
Caprion Proteomics
Celgene
Cell Genesys
Centocor
Centre for Addiction and Mental Health
Centrum Foundation
CeraPedics
ChemBridge Research Laboratories
Chiron
Christopher Reeve Paralysis Foundation
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Craig H. Neilsen Foundation
CSL
CV Therapeutics
Cyanamid
Cyclacel Pharmaceuticals